Work

FIGURE 1 from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer

Year: 2023

Type: other

Abstract: Kaplan–Meier estimates of OS and PFS in the expansion cohort. A, shows OS; the median was 11 months. B, shows PFS; the median was 8.3 months.

DOI: 10.1158/2767-9764.24043028.v1

Authors: H. Catherine Wilbur, Jennifer N. Durham, Su Jin Lim, Katrina Purtell, Katherine M. Bever, Daniel A. Laheru, Ana De Jesus-Acosta, Nilofer S. Azad, Bradley Wilt, Luis A. Diaz, Dung T. Le, Hao Wang

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4386216074

Cites:

Cited by:

Related to: 10